RUNX1 and neoplasm: Furthermore, higher RUNX1 levels observed in RRMM patients, despite stable overall expression across ISS stages, suggests that RUNX1 may be reactivated or maintained during disease recurrence, possibly contributing to reshaping of transcriptional networks to favor tumor persistence.